Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
Raisa S PompePhilipp GildPierre I KarakiewiczLea-Philine BockThorsten SchlommThomas SteuberMarkus GraefenHartwig HulandZhe TianDerya TilkiPublished in: The Prostate (2018)
Only a small proportion of BCR patients proceed to MP or PCSM. Besides higher GS and rapid PSA-DT a shorter RP-BCR interval (<12 months) heralds the most aggressive phenotype for progression to all three examined endpoints: MP, PCSM, and OM.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- acute lymphoblastic leukemia
- newly diagnosed
- tyrosine kinase
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- chronic myeloid leukemia
- type diabetes
- squamous cell carcinoma
- adipose tissue
- metabolic syndrome
- squamous cell
- patient reported outcomes